GPCM
IMVTW

Granite Point Capital Management’s Immunovant, Inc. Warrants expiring 12/18/2024 IMVTW Stock Holding History

Granite Point Capital Management’s Portfolio IMVTW Stock Details IMVTW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-250,000
Closed -$600K – 163
2020
Q1 		$600K Buy
+250,000
New +$480K 0.34% 62

Granite Point Capital Management's IMVTW Position: Q2 2020 in Review

Granite Point Capital Management sold out of Immunovant, Inc. Warrants expiring 12/18/2024 (IMVTW) in Q2 2020, closing a stake of 250,000 shares — an estimated $600K sold.

Granite Point Capital Management first reported a position in IMVTW in Q1 2020 and held it in 1 quarter. The position peaked at $600K in Q1 2020. 0 funds tracked by Wall St. Rank hold IMVTW as of Q2 2020.

  • Granite Point Capital Management reported no remaining Immunovant, Inc. Warrants expiring 12/18/2024 position as of Q2 2020 after selling out during the quarter.
  • Granite Point Capital Management sold 250,000 Immunovant, Inc. Warrants expiring 12/18/2024 shares in Q2 2020, an estimated $600K.
  • Granite Point Capital Management first reported a position in Immunovant, Inc. Warrants expiring 12/18/2024 in Q1 2020 and held it in 1 quarter.
  • Granite Point Capital Management's Immunovant, Inc. Warrants expiring 12/18/2024 position peaked at $600K in Q1 2020.
  • 0 funds tracked by Wall St. Rank held Immunovant, Inc. Warrants expiring 12/18/2024 as of Q2 2020.

Based on Granite Point Capital Management's 13F filing for Q2 2020, filed 12 Aug 2020.